Seizure. Epilepsy and recurrent seizures
Conditions
Interventions
Intervention 1: Intervention group 1: Melatonin tablets (Three milligrams) from Razak Pharmaceutical Company with a dose of 0.4 Milligram per Kilogram, dissolved in water, were given to the patients o
Sponsors
Gorgan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
6 Months to 5 Years
Inclusion criteria
Inclusion criteria: The existence of seizures or other seizure-like attacks requiring electroencephalography examination Age between six months to five years Class one and two of the American Society of Anesthesiologists (ASA) classification Complete relative sleep deprivation
Exclusion criteria
Exclusion criteria: Severe allergic reaction to Chloral hydrate and Melatonin History of recent head injury Use of Sedation drugs in the last two days Other severe systemic diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sedation induction. Timepoint: From the beginning to the end of sedation. Method of measurement: Ramsay Sedation Score to determine success or failure of sedation. | — |
Secondary
| Measure | Time frame |
|---|---|
| Sedation onset. Timepoint: Sedation score 4 and above based on Ramsay Sedation Score (RSC). Method of measurement: Ramsay Sedation Score.;Sedation Duration. Timepoint: The interval between complete sedation and withdrawal from sedation. Method of measurement: Steward Recovery Score.;Recovery time. Timepoint: The interval between complete withdrawal from sedation and complete recovery. Method of measurement: Calculate time in hours and minutes using a clock.;Side effects. Timepoint: After recovery. Method of measurement: Patient assessment.;Epileptiform discharges in Electroencephalography (EEG). Timepoint: After Electroencephalography (EEG) recording. Method of measurement: Examination by a neurologist. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyed-Ahmad Hosseini
Gorgan University of Medical Sciences
Outcome results
None listed